All Assays.
One Digital Platform.
Genedata Screener® automates assay analysis, validates raw data and assay result quality, and consolidates assay information across the enterprise and external collaborators. By integrating and condensing complex experimental data, it accelerates project decisions and lays the foundation for more predictive, AI-powered drug discovery and development.
Our Customers
Genedata Screener is flexible and scalable, satisfying all our needs for high, medium, and low experimental throughputs
We believe that Genedata Screener is the gold standard for screening data analysis.
Genedata Screener is one of the standard screening platforms for many of our pharmaceutical customers.
Genedata Screener helps us to access unexplored biology that can’t be examined any other way.
Genedata Screener Applications
- High-Throughput Screening
- Large Molecule Assays
- High Content Assays
- Multiplexed Assays
- Biophysical Characterization & Screening
- Pharmacological & Mechanistic Analysis
From Primary Screening to Hit Validation
Streamline your research workflow from primary screening through hit validation and lead development. Genedata Screener supports scalable screening using biochemical, biophysical, and cellular assays, as well as other advanced screening modalities, including label-free technologies such as high-throughput mass spectrometry.
Discover how end-to-end automation and data-driven decisions are transforming screening — making it faster, more efficient, and more insightful than ever before.
Learn More
Advanced Large Molecule Research
Accelerate large molecule discovery, one of the fastest-growing modalities in drug development, with Genedata Screener. Promising more targeted and personalized therapies, large molecule R&D spans multiple stages, from molecule engineering to optimization, each requiring a range of targeted and functional assays. Genedata Screener supports key assays across the workflow, including plate-based immunoassays, cellular assays, high-throughput flow cytometry, epitope binning, and biophysical assays such as surface plasmon resonance (SPR) and bio-layer interferometry (BLI).
Discover how Genedata Screener enables scalable, automated analysis across the entire large molecule workflow — driving faster, more confident decisions.
Learn More
Image-Based High-Content Screening
Unlock new therapeutic insights with image-based high-content screening (HCS). By combining target-agnostic approaches, physiologically relevant models, and information-rich imaging, HCS enables discovery of novel mechanisms but also generates complex, multiparametric data that can be challenging to interpret. Genedata Screener provides an end-to-end solution for HCS analysis, streamlining data interpretation and enabling consistent application across the discovery pipeline.
Discover how Genedata Screener simplifies HCS — making it faster, more scalable, and more insightful.
Learn More
Comprehensive Analysis of Complex Assays
Gain deeper insights with multiplexed assays that generate tens to hundreds of measurements per sample, revealing leads often missed by single-endpoint approaches and enabling more complete characterization of candidate molecules.
This data-rich format presents challenges for processing and interpretation. Genedata Screener streamlines quality control and analysis of multidimensional results from multiplexed assays, including flow cytometry, transcriptomic profiling, and combination screening.
Discover how Genedata Screener empowers reliable, scalable analysis of complex assay data — accelerating decision-making across the discover pipeline.
Learn More
Streamlined Analysis of Molecular Interactions
Characterize molecular interactions and stability with biophysical screening technologies such as impedance, SPR, BLI, and thermal shift assay (TSA). These assays are supported by diverse instruments with varying analysis methods, often requiring manual, step-by-step workflows and lacking batch processing capabilities. Genedata Screener simplifies this process with ready-to-use workflows that eliminate repetitive tasks and enable seamless data integration across plates and instruments.
Discover how Genedata Screener accelerates biophysical screening — reducing manual effort and enabling faster, more reproducible results.
Learn More
In Vitro ADME-Tox and Mechanism-of-Action Studies
Mitigate risk in early drug discovery with standardized pharmacological and mechanistic analysis. Poor toxicity profiles and suboptimal PK/PD can derail promising leads. Genedata Screener enables rigorous ADME-Tox, kinetic characterization, and target engagement studies early in the discovery pipeline, greatly increasing the likelihood of success.
The platform automates and harmonizes analysis of in vitro ADME, toxicity assays, and mechanism-of-action studies, ensuring reliable, reproducible results.
Discover how Genedata Screener supports early decision-making — reducing risk and accelerating development.
Learn MoreDiscover Genedata Screener
Digital Backbone for the Lab of the Future
Transform drug discovery and development by automating your data workflows. Genedata Screener enables seamless retrieval of assay data and metadata from instruments, automated analysis and quality control, and centralized reporting to global teams.
With FAIR (findable, accessible, interoperable, reusable) and AI-ready data, Genedata Screener provides the digital backbone for your modern lab — helping you do science more efficiently.
Learn More
Data-Driven Decision-Making
Make better decisions faster, with structured and consolidated assay data. In drug discovery, critical R&D decisions rely on assay results that are often scattered across internal teams and external collaborators.
Genedata Screener organizes, annotates, and harmonizes assay data — laying the foundation for AI-powered predictions and confident, data-driven decision-making.
Learn More
Seamless Connectivity Across Your Ecosystem
Connect Genedata Screener with a wide range of instruments and software used in screening workflows — from plate readers and imaging systems to ELNs and LIMS. Its open architecture and flexible APIs ensure smooth integration, enabling automated data flow and reducing manual effort.
Discover how Genedata Screener streamlines your digital ecosystem — boosting efficiency and enabling end-to-end automation.
Learn MoreLearn How We Support Screening Assays
Why Choose Genedata Screener for Assay Data Analysis?
Genedata Screener empowers biopharmaceutical organizations to make faster, insight-driven decisions by unlocking the full potential of multimodal screening data. It automates complex, multimodal assay workflows, centralizes structured data for downstream analysis, and ensures high data quality and reproducibility. By eliminating manual bottlenecks and integrating seamlessly into evolving R&D environments, Genedata Screener enables scientists and research-IT teams to accelerate discovery and collaborate more effectively.
- Centralizes Screening Data
- Accelerates Discovery at Scale
- Ensures High-Quality, Reproducible Results
- Enables Seamless Collaboration
- Supports GxP and Regulatory Compliance
- Adapts to Evolving Screening Needs
Unify All Screening Analysis on One Platform
Genedata Screener centralizes all screening data in a scalable, modality-agnostic platform. Scientifically validated workflows and predefined analysis steps standardize data processing, while automated reporting and structured data management make results findable, accessible, and ready for downstream use. The platform streamlines workflows across instruments, enables secure collaboration with internal teams and CROs, and ensures consistent reporting through controlled vocabularies, supporting confident decision-making and future data queries.
Scale Assays and Shorten R&D Timelines
Genedata Screener accelerates discovery by processing large, complex datasets in minutes. Automated data capture, calculations, and multi-level quality control streamline analysis as soon as experiments conclude. Intuitive wizards and raw data import enable instant analysis, while flexible workflows optimize production-scale assays. With automated curve-fitting, model selection, and multiplexing, Genedata Screener delivers per-molecule results faster — helping teams identify promising leads earlier.
Built-In Scientific Intelligence for Reliable Outcomes
Genedata Screener ensures high-quality, reproducible results by applying standard QC criteria, flagging suspect data, and enabling interactive review of analysis parameters. Any adjustments trigger automatic recalculation across entire datasets, preserving consistency and scientific rigor. Advanced fitting algorithms, validated models, and current scientific methods minimize manual errors, apply best-practice analysis, and provide dynamic visualizations for additional QC.
Collaborate Without Barriers Across Teams and Locations
Genedata Screener centralizes assay data for instant access, enabling real-time collaboration across departments, disciplines, and global sites. Structured, secure data access keeps biologists, chemists, and data scientists aligned. The platform accelerates decision-making, supports cross-functional teamwork on a unified data foundation, and provides secure, cloud-based access so distributed teams and external partners can work together without friction.
Built for Compliance and Regulatory Confidence
Genedata Screener ensures data integrity, traceability, and inspection-ready processes for regulated environments. Validation-ready workflows, SOP integration, and standardized processes maintain GxP compliance, while detailed documentation and training resources simplify audits and meet regulatory expectations. Sensitive data is protected through encryption, role-based access, and secure deployment options. Immutable records and complete audit logs deliver transparency for smooth inspections and long-term traceability.
Scalable Architecture for Next-Generation Screening
Genedata Screener evolves with your screening environment, delivering flexibility, scalability, and seamless integration across assays and teams. Scientifically validated workflows support diverse formats, including Ion Channel, Kinetic, Mass Spectrometry, and High-Content Screening. The platform integrates with imaging systems and lab software to unify data, scales with changing requirements without custom development, and captures assay data and IP throughout the R&D lifecycle to drive innovation and ensure traceability.
